The impasse over US drug reimportation may be a blessing in disguise
This article was originally published in SRA
The growth of expenditures on prescription drugs in the US is prompting consumers and policy makers to explore alternative routes to control drug spending. Senior citizens and uninsured people have been among the hardest-hit populations during the latest economic recession in particular and consumers have been forced to live with difficult choices. Some 15-25% of the population has reported not filling a prescription on time and/or reducing a prescribed dosage due to lack of affordability1,2.
You may also be interested in...
Washington State Ecology Mulls ‘Safer’ Definition While Exploring Phthalate Alternatives In Fragrances
Marissa Smith, senior regulatory toxicologist in the Washington Department of Ecology’s Hazardous Waste and Toxics Reduction program, discusses what’s next for the state’s inaugural Safer Products go-round. “How we define ‘safer’ is really going to be the lynchpin of this whole process,” she says.
Class action complaints filed in 2020 against food, dietary supplement and beverage firms should pass 2019’s total as COVID-19 has not slowed litigants but has given plaintiffs’ council more time out of court to shop for new cases.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.